C
Carlo M. Croce
Researcher at Ohio State University
Publications - 1156
Citations - 199822
Carlo M. Croce is an academic researcher from Ohio State University. The author has contributed to research in topics: microRNA & Cancer. The author has an hindex of 198, co-authored 1135 publications receiving 189007 citations. Previous affiliations of Carlo M. Croce include University of Nebraska Medical Center & University of California, Los Angeles.
Papers
More filters
Journal ArticleDOI
BRCA1 5083del19 mutant allele selectively up-regulates periostin expression in vitro and in vivo.
Barbara Quaresima,Francesco Romeo,Maria Concetta Faniello,Maddalena Di Sanzo,Chang Gong Liu,Annamaria Lavecchia,Cristian Taccioli,Eugenio Gaudio,Francesco Baudi,Francesco Trapasso,Carlo M. Croce,Giovanni Cuda,Francesco Costanzo +12 more
TL;DR: The results suggest that periostin overexpression might be a potential marker for early cancer detection in a specific subset of hereditary breast carcinomas triggered by cancer-associated BRCA1 mutations that affect the BRCT tandem domain.
Journal ArticleDOI
Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner
Joshua Armenia,Linda Fabris,Francesca Lovat,Stefania Berton,Ilenia Segatto,Sara D'Andrea,Cristina Ivan,Luciano Cascione,George A. Calin,Carlo M. Croce,Alfonso Colombatti,Andrea Vecchione,Barbara Belletti,Gustavo Baldassarre +13 more
TL;DR: An expression profiling approach provides evidence that the CDK inhibitor p27Kip1 regulates miRs expression following cell cycle exit following contact inhibition, and proposes a new role for miR-223 in the regulation of breast cancer progression.
Journal ArticleDOI
MicroRNAs in Skeletal Muscle and Hints on Their Potential Role in Muscle Wasting During Cancer Cachexia.
TL;DR: The most recent findings concerning the role of microRNAs in triggering or exacerbating muscle wasting in cancer cachexia are discussed, while mentioning about possible roles played by long non-coding RNAs and ADAR-mediated miRNA modifications.
Journal ArticleDOI
Human HMGA2 protein overexpressed in mice induces precursor T-cell lymphoblastic leukemia.
Alexey Efanov,Nicola Zanesi,Vincenzo Coppola,Gerard J. Nuovo,Brad Bolon,D Wernicle-Jameson,Alessandro Laganà,A Hansjuerg,Flavia Pichiorri,Carlo M. Croce +9 more
TL;DR: HMGA2-driven leukemia in mice closely resembles spontaneous human T-ALL, indicating that HMGA2 transgenic mice should serve as an important model for investigating basic mechanisms and potential new therapies of relevance to human T -ALL.
Journal ArticleDOI
Cancer prevention and therapy in a preclinical mouse model: impact of FHIT viruses.
Hideshi Ishii,Andrea Vecchione,Louise Y.Y. Fong,Nicola Zanesi,Francesco Trapasso,Yusuke Furukawa,Raffaele Baffa,Kay Huebner,Carlo M. Croce +8 more
TL;DR: In vitro analyses and in vivo tumorigenicity studies show that restoration of Fhit protein induces tumor suppression in 50% of tumor cell lines tested, and viral vector-mediated FHIT gene transfer to Fhit-deficient mice not only prevents but reverses the carcinogen-induced tumor development in vivo, in accordance with the oncosuppressive properties of F hit protein.